RELATED STUDY
GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
Key Findings: CBD is an inverse agonist for GPR3, GPR6, and GPR12 and as such may play a therapeutic role for conditions such as Alzheimer's disease, Parkinson's disease, cancer, and infertility for example.
Type of Study: Laboratory Study
Study Result: Positive
Study Location(s): United States
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype III
Receptors Studied: GPCR 3, GPCR 6
